Market Overview

UPDATE: Deutsche Bank Downgrades HealthSouth Corporation to Hold; Valuation Full

Share:
Related HLS
Earnings Scheduled For February 24, 2015
What To Expect From Athenahealth's Earnings (Hint: Analysts Aren't Impressed)
Amsurg (AMSG) Beats Q4 Earnings, Revenues; Outlook Bright - Analyst Blog (Zacks)

Deutsche Bank downgraded HealthSouth Corporation (NYSE: HLS) from Buy to Hold and lowered the price target from $28.50 to $25.00.

Deutsche Bank commented, "HLS' revenue growth prospects remain underpinned by good organic volume trends, acceleration of de novos and JV/M&A opportunities. Despite our favorable view for "HLS the company," we see a more balanced risk/reward for "HLS the stock," with the potential for Medicare pressure over the next 12-24 months the key gaiting factor for HLS' valuation multiple. Hold more accurately reflects our stance on HLS shares."

HealthSouth Corporation closed at $23.86 on Thursday.

Latest Ratings for HLS

DateFirmActionFromTo
Feb 2015BarclaysMaintainsEqualweight
Jan 2015BarclaysMaintainsEqual-weight
Jul 2014BarclaysMaintainsEqual-weight

View More Analyst Ratings for HLS
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Downgrades Analyst Ratings

 

Related Articles (HLS)

Around the Web, We're Loving...

Get Benzinga's Newsletters